Role of 10-Gy boost radiation after breast-conserving surgery for stage I-II breast cancer with a 5-mm negative margin

被引:6
|
作者
Notani, Masafumi [1 ]
Uchida, Nobue [1 ]
Kitagaki, Hajime [1 ]
机构
[1] Shimane Univ, Fac Med, Dept Radiol, Izumo, Shimane 6938501, Japan
关键词
boost radiation; breast cancer; breast-conserving therapy; negative margin;
D O I
10.1007/s10147-007-0673-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background According to the Guidelines for breast-conserving therapy of the Japanese Breast Cancer Society, the surgical margin is "negative" when the minimum distance between the tumor edge and the margin of the resected specimen is more than 5mm. The value of boost radiation for early breast cancer with a 5-mm negative margin remains unclear. Methods. A total of 137 patients with stage I-II breast cancer underwent breast-conserving surgery between July 1987 and August 2002. All of the patients had negative margins according to the Japanese guidelines. Their median age was 50 years and the median follow-up period was 62 months. The entire ipsilateral breast was irradiated to a total dose of 50 Gy (25 fractions). Then an additional 10 Gy (5 fractions) was given to 79 patients, using 6- to 12-MeV electrons (boost group), while 58 patients (no-boost group) received no further radiation. Factors influencing local recurrence were evaluated by univariate and multivariate analyses. Results. For the entire population, the 5-year overall survival, cause-specific survival, disease-free survival, and local recurrence rates were 96.0%, 96.8%, 94.2%, and 1.67%, respectively. Boost radiation reduced local recurrence, but the improvement was not significant (P = 0.070). Univariate and multivariate analyses failed to detect any factors that were significantly associated with local control. There were no severe complications in either group and there were no differences between the groups in the cosmetic outcome. Conclusion. Boost radiation can be performed for stage I-II breast cancer with negative margins (Japanese guidelines), and showed a tendency to decrease local recurrence. A large randomized controlled study is necessary to establish final conclusions.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 50 条
  • [41] Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer
    Meena S. Moran
    Stuart J. Schnitt
    Armando E. Giuliano
    Jay R. Harris
    Seema A. Khan
    Janet Horton
    Suzanne Klimberg
    Mariana Chavez-MacGregor
    Gary Freedman
    Nehmat Houssami
    Peggy L. Johnson
    Monica Morrow
    Annals of Surgical Oncology, 2014, 21 : 704 - 716
  • [42] Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery
    Danielle Rodin
    Rinku Sutradhar
    Katarzyna J. Jerzak
    Ezra Hahn
    Lena Nguyen
    Matthew Castelo
    Omolara Fatiregun
    Cindy Fong
    Danilo Giffoni M. M. Mata
    Sabina Trebinjac
    Lawrence Paszat
    Eileen Rakovitch
    Breast Cancer Research and Treatment, 2023, 201 : 77 - 87
  • [43] Adjuvant Regional Irradiation after Breast-conserving Therapy for Early Stage Breast Cancer: a Survey of Canadian Radiation Oncologists
    Clavel, S.
    Roy, I.
    Carrier, J. -F.
    Rousseau, P.
    Fortin, M. -A.
    CLINICAL ONCOLOGY, 2010, 22 (01) : 39 - 45
  • [44] Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis
    Mira Goldberg
    Rinku Sutradhar
    Lawrence Paszat
    Timothy J. Whelan
    Sumei Gu
    Cindy Fong
    Eileen Rakovitch
    Breast Cancer Research and Treatment, 2019, 176 : 657 - 667
  • [45] Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery
    Rodin, Danielle
    Sutradhar, Rinku
    Jerzak, Katarzyna J.
    Hahn, Ezra
    Nguyen, Lena
    Castelo, Matthew
    Fatiregun, Omolara
    Fong, Cindy
    Mata, Danilo Giffoni M. M.
    Trebinjac, Sabina
    Paszat, Lawrence
    Rakovitch, Eileen
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (01) : 77 - 87
  • [46] Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis
    Goldberg, Mira
    Sutradhar, Rinku
    Paszat, Lawrence
    Whelan, Timothy J.
    Gu, Sumei
    Fong, Cindy
    Rakovitch, Eileen
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (03) : 657 - 667
  • [47] Locoregional recurrences after conservative treatment of breast cancer stage I-II
    Raspall, MJF
    Serra, EP
    Verdum, JI
    Muñoz, CA
    González, BO
    Gómez, AG
    Ollé, AL
    Pires, DD
    Puertas, EL
    de Grignon, JCBL
    López, AL
    Folch, MT
    MEDICINA CLINICA, 2002, 118 (05): : 161 - 165
  • [48] The effect of radiotherapy on patients with pathological stage IIB breast cancer after breast-conserving surgery or mastectomy: A cohort study
    Pan, Yi-Ying
    Lai, Tzu-Yu
    Shiau, Cheng-Ying
    Tseng, Ling-Ming
    Lai, I-Chun
    Liu, Yu-Ming
    Huang, Pin-, I
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2024, 87 (02) : 202 - 211
  • [49] Helical Tomotherapy of Lymph Node-negative Early-stage Breast Cancer After Breast-conserving Surgery: Long-term Results
    Zwicker, Felix
    Klepper, Rudolf
    Hauswald, Henrik
    Hoefel, Sebastian
    Raether, Luis
    Huber, Peter E.
    Debus, Juergen
    Schempp, Michael
    ANTICANCER RESEARCH, 2023, 43 (05) : 2041 - 2053
  • [50] Effect of high-dose radiation therapy on positive margins after breast-conserving surgery for invasive breast cancer
    Kim, Hyunjung
    Kim, Tae Gyu
    Park, Byungdo
    Kim, Jeong Ho
    Jun, Si-Youl
    Lee, Jun Ho
    Choi, Hee Jun
    Jung, Chang Shin
    Bang, Yoon Ju
    Lee, Hyoun Wook
    Lee, Jae Seok
    Nam, Hyun Yeol
    Shin, Seunghyeon
    Kim, Sung Min
    Kim, Haeyoung
    BREAST, 2023, 71 : 106 - 112